The Founder's Guide to

Scientia Ventures

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Founded in 2020, Scientia Ventures is a New York-based venture capital firm specializing in early to mid-stage investments in the life sciences sector. The firm focuses on computational biology, digitization of medicine, and digital therapies, with a portfolio that includes notable companies like Royalty Pharma and ADC Therapeutics. Scientia Ventures emphasizes building new companies around identified innovations and partnering with existing firms to accelerate growth.

Learn More

Frequently Asked Questions

Does Scientia Ventures lead rounds?

Yes, Scientia Ventures often leads investment rounds, particularly in early-stage companies where they can provide strategic guidance and support.

What is Scientia Ventures' stance on follow-on investments?

The firm is open to follow-on investments, especially in companies that demonstrate significant growth and potential for commercialization.

How large is Scientia Ventures' current fund?

Specific fund size details are not publicly disclosed, but the firm focuses on early to mid-stage investments across its portfolio.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.